Evusheld recommended for market authorisation in EU
Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months
Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months
The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies
The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Sputnik Light is the first component of Sputnik V
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
Subscribe To Our Newsletter & Stay Updated